Early suppression of basophil activation during allergen-specific immunotherapy by histamine receptor 2 The Journal of Allergy and Clinical Immunology, 06/15/2012

Novak N et al. – Immunosilencing of FcεRI–activated basophils by means of selective suppression mediated by H2R might be highly relevant for the very early induction of allergen tolerance and the so–called desensitization effect of venom immunotherapy (VIT).

Read this article on The Journal of Allergy and Clinical Immunology

Print Article | Back to Articles

Stay current on the latest literature, research and clinical news
Get special communications and offers from MDLinx and our sponsors
Receive invitations to paid market research

View Samples and Register

Stay current - Media Tool

Newsletter

RSS

Facebook

Receive free subspecialty
"5-minute updates" via email

Send the E-mail Newsletter to a Colleague

♦ Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More ♦

♦ Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More ♦

♦ Follow Us on Facebook

Search the latest
Allergy/Immunology Jobs
@MDLinx Career Center
View the full listing of physician jobs

Enter your email address and your password will be sent to you.
Email:

E-mail:
Password:
	Remember me Forgot your password?